HER2 Guidelines for Breast Cancer Could Misclassify Some Patients

The ASCO-CAP guidelines for HER2 gene amplification testing leave some patients at risk for misclassification and inappropriate treatment.

Source: CancerNetwork - March 16, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news